Quantcast

Latest Lilly Stories

2014-03-05 16:26:36

INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Barclays Global Healthcare Conference on Wednesday, March 12, 2014. David Ricks, Lilly senior vice president, and president of Lilly Bio-Medicines, will participate in a fireside chat at 1:00 p.m. EDT. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a replay of the fireside...

2014-03-05 12:26:22

Boehringer Ingelheim and Lilly are committed to working with the FDA RIDGEFIELD, Conn. and INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (Lilly; NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. The complete response letter...

2014-02-24 08:28:13

Deal Provides Elanco with a Leading Poultry Vaccine Portfolio and Manufacturing Capabilities GREENFIELD, IN, Feb. 24, 2014 /PRNewswire/ -- Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY), today announced an agreement to acquire Lohmann SE (Lohmann Animal Health), a privately-held company headquartered in Cuxhaven, Germany. Lohmann Animal Health is a global leader in the supply of poultry vaccines and also markets a range of feed additives. The acquisition will...

2014-02-21 12:24:54

INDIANAPOLIS, Feb. 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will attend the 34(th) Annual Cowen and Company Healthcare Conference on Tuesday, March 4, 2014. Derica Rice, Lilly executive vice president, global services, and chief financial officer, will participate in a fireside chat at 11:20 a.m. EST. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a...

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...

2014-02-05 16:30:56

JourneyEd.com and AcademicSuperStore.com are now under new ownership, and the conjoined education company is making significant changes to its customer experience DALLAS, Feb. 5, 2014 /PRNewswire/ -- JourneyEd.com and AcademicSuperStore.com are now under new ownership. Greg Lamkin is the new CEO, while Tim Lilly fills the role of president, and the consolidated company will be named JourneyEd.com, Inc. Greg Lamkin has been with JourneyEd.com for over 10 years, beginning as a...

2014-02-05 16:27:52

INDIANAPOLIS, Feb. 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Swann Global Healthcare Conference on Wednesday, February 12, 2014. Jan M. Lundberg, Ph.D., executive vice president of science and technology and president of Lilly Research Laboratories, will discuss Lilly's pipeline in a fireside chat at 8:25 a.m. EST. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at...

2014-01-31 12:25:16

INDIANAPOLIS, Jan. 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided the following statement regarding a lawsuit filed by Sanofi in the United States District Court for the District of Delaware alleging patent infringement with respect to LY2963016, a new insulin glargine product for which Lilly is currently seeking approval from the U.S. Food and Drug Administration (FDA). "Lilly respects the intellectual property of others and does not believe the...

2014-01-30 08:29:45

INDIANAPOLIS, Jan. 30, 2013 /PRNewswire/ -- -- Fourth-quarter 2013 revenue declined 2 percent driven by Cymbalta U.S. patent expiration, partially offset by growth in other products. -- Fourth-quarter 2013 earnings per share were $0.67 (reported), or $0.74 (non-GAAP). -- Full-year 2013 revenue increased 2 percent to $23.1 billion. -- Full-year 2013 earnings per share totaled $4.32 (reported), or $4.15 (non-GAAP). -- Approximately $3.8 billion...

2014-01-23 23:29:37

The partnership will raise funds and awareness for the American Diabetes Association throughout the 2014 NASCAR Nationwide Series racing schedule. Houston, TX (PRWEB) January 23, 2014 The NASCAR Nationwide Series race calendar opens up this year, as it usually does, at the Daytona International Speedway, a monument to the history of racing both past and present. This year the race will feature Ryan Reed, an incredibly talented driver who never let his type 1 diabetes diagnosis slow him...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.